BridgeMD
New treatment option for Chronic Liver Disease
Official title Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
ClinicalTrials.gov ID: NCT06318949
What this study is testing
- What it's testing
- Chronic liver diseases, affecting over 800 million people worldwide, lead to approximately 2 million annual deaths. The need for early, sensitive diagnostic strategies to prevent disease progression and reduce mortality is still unmet.
- Time commitment: about 3 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- At least 18 years old
- With a compensated fibrosis defined by an hepatic elasticity ≥10 kPa measured by FibroScan®
- Having had blood test at the hospital as part of a consultation or an hospitalisation at the inclusion including usual parameters for the liver...
- Affiliated with or beneficiaries of a social security system
- Not opposed to participate to the study after being informed
You likely can't join if
- Patients suffering from decompensated cirrhosis or with an history of decompensated cirrhosis
- Patients who received an albumin infusion in the month before the inclusion visit
- Patients suffering from stage 4 or 5 renal failure (GFR \< 29 ml/min/1,73m²)
- Patients suffering from cancer
- Pregnant or breastfeeding women or women of childbearing age without effective contraception (based on declaration)
- Patients suffering from impairment of mental faculties or a psychiatric disorder which could interfere with the understanding of the study
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Limoges, France
- Poitiers, France
- Rennes, France
- Toulouse, France
- Tours, France
- Pointe-à-Pitre, Guadeloupe
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Limoges, France; Poitiers, France; Rennes, France; Toulouse, France; Tours, France and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.